Követés
Bíborka Dr. Nádró
Bíborka Dr. Nádró
Debreceni Egyetem Belgyógyászati Intézet
E-mail megerősítve itt: belklinika.com
Cím
Hivatkozott rá
Hivatkozott rá
Év
HDL subfraction distribution and HDL function in untreated dyslipidemic patients
M Harangi, A Szentpéteri, B Nádró, H Lőrincz, I Seres, D Páll, G Paragh
undefined 1, 166-173, 2017
212017
Effects of alpha-lipoic acid treatment on serum progranulin levels and inflammatory markers in diabetic neuropathy
B Nádró, H Lőrincz, Á Molnár, A Szentpéteri, E Zöld, I Seres, D Páll, ...
Journal of International Medical Research 49 (5), 03000605211012213, 2021
202021
The role of apolipoprotein M and sphingosine 1-phosphate axis in the prevention of atherosclerosis
B Nádró, L Juhász, A Szentpéteri, D Páll, G Paragh, M Harangi
Orvosi Hetilap 159 (5), 168-175, 2018
142018
Determination of serum progranulin in patients with untreated familial hypercholesterolemia
B Nádró, H Lőrincz, L Juhász, A Szentpéteri, F Sztanek, É Varga, D Páll, ...
Biomedicines 10 (4), 771, 2022
92022
Sphingosine 1-phosphate and apolipoprotein M levels and their correlations with inflammatory biomarkers in patients with untreated familial hypercholesterolemia
L Juhász, H Lőrincz, A Szentpéteri, B Nádró, É Varga, G Paragh, ...
International Journal of Molecular Sciences 23 (22), 14065, 2022
52022
Determining the prevalence of childhood hypertension and its concomitant metabolic abnormalities using data mining methods in the Northeastern region of Hungary
B Kovács, Á Németh, B Daróczy, Z Karányi, L Maroda, Á Diószegi, ...
Frontiers in Cardiovascular Medicine 9, 1081986, 2023
32023
Diagnostic and prognostic roles of serum progranulin, a novel marker of the carbohydrate metabolism and inflammation
B Nádró, F Sztanek, H Lőrincz, D Páll, G Paragh, M Harangi
Orvosi Hetilap 160 (25), 973-979, 2019
22019
Changes in HDL subfraction distribution and myeloperoxidase/paraoxonase-1 ratio in untreated dyslipidemic patients
B Nadro, A Szentpeteri, H Lorincz, L Juhasz, I Seres, D Pall, G Paragh, ...
Atherosclerosis 275, e168, 2018
22018
P76 Carotid Artery Disease in Patients with Newly Diagnosed, Untreated Familial Hypercholesterolemia
B Nádró, B Kovács, Á Diószegi, L Juhász, D Páll, G Paragh, M Harangi
Artery Research 25 (Suppl 1), S119-S119, 2019
12019
Smart medical report: efficient detection of common and rare diseases on common blood tests
Á Németh, G Tóth, P Fülöp, G Paragh, B Nádró, Z Karányi, G Paragh Jr, ...
Frontiers in Digital Health 6, 1505483, 2024
2024
Are we there yet? AI on traditional blood tests efficiently detects common and rare diseases
Á Németh, G Tóth, P Fülöp, G Paragh, B Nádró, Z Karányi, G Paragh Jr, ...
2024
ESTIMATING THE PREVALENCE OF CHILDHOOD HYPERTENSION AND ITS CONCOMITANT METABOLIC ABNORMALITIES IN THE NORTHEASTERN REGION OF HUNGARY USING DATA MINING METHODS
D Pall, B Kovacs, A Nemeth, B Daroczy, Z Karanyi, L Maroda, M Zrinyi, ...
Journal of Hypertension 42 (Suppl 1), e99, 2024
2024
ASSESSMENT OF HYPERTENSIVE PATIENTS’COMPLEX METABOLIC STATUS IN THE NORTHEASTERN REGION OF HUNGARY USING DATA MINING METHODS
B Kovacs, A Nemeth, B Daroczy, Z Karanyi, L Maroda, M Zrinyi, ...
Journal of Hypertension 42 (Suppl 1), e3, 2024
2024
Elevated sphingosine 1-phosphate level in familial hypercholesterolemic patients
L Juhász, H Lőrincz, A Szentpéteri, B Nádró, É Varga, G Paragh, ...
Atherosclerosis 379, S118, 2023
2023
Beáta Kovács1, Ákos Németh1, Bálint Daróczy2, 3, Zsolt Karányi1, László Maroda4, Ágnes Diószegi1, Bíborka Nádró1, Tamás Szabó5, Mariann Harangi1 and Dénes Páll4
B Kovács, Á Németh, B Daróczy, Z Karányi, L Maroda, Á Diószegi, ...
Blood pressure in children and adolescents: Moving forward, 80, 2023
2023
Serum progranulin level in patients with newly diagnosed untreated familial hypercholesterolemia
B Nádró, H Lőrincz, L Juhász, A Szentpéteri, F Sztanek, I Seres, D Páll, ...
Atherosclerosis 355, 166, 2022
2022
Cardiovascular risk factors in newly diagnosed, untreated Hungarian patients with familial hypercholesterolemia
L Juhász, B Nádró, N Zsíros, G Paragh, M Harangi
Atherosclerosis 331, e181, 2021
2021
Characterization of dyslipidemic patients with apolipoprotein E 2/2 genotype
B Nádró, L Juhász, M Jalil, I Balogh, G Paragh, M Harangi
Atherosclerosis 331, e181, 2021
2021
A lipoprotein (a) jelentősége a szív-és érrendszeri megbetegedések kialakulásában
N Zsíros, B Nádró, M Harangi
2021
Changes in serum progranulin level and inflammatory markers in diabetic neuropathy
F Sztanek, B Nádró, E Zöld, H Lőrincz, A Szentpéteri, Á Molnár, D Páll, ...
Atherosclerosis 315, e202-e203, 2020
2020
A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.
Cikkek 1–20